Lanfix Tablet is a combination antibiotic formulation containing Cefixime 200mg and Clavulanic Acid 125mg, designed to provide broad-spectrum antibacterial activity. Cefixime, a third-generation cephalosporin, exerts its bactericidal effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Cefixime by preventing the enzymatic degradation of the antibiotic by beta-lactamase-producing bacteria. This synergistic combination is effective against a wide range of gram-positive and gram-negative pathogens, including strains resistant to beta-lactam antibiotics. Lanfix Tablet is indicated for the treatment of various infections such as respiratory tract infections, urinary tract infections, otitis media, skin and soft tissue infections, and uncomplicated gonorrhea. It is essential to use Lanfix Tablet as prescribed by a healthcare professional to ensure optimal therapeutic outcomes and minimize the risk of resistance development. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Caution is advised in patients with a history of hypersensitivity to cephalosporins or penicillins. Renal function should be monitored during prolonged therapy. Lanfix Tablet should be stored in a cool, dry place away from direct sunlight and out of reach of children.